Compare Aileron Therapeutics vs Incept Biosystems
Customers evaluate the quality of Aileron Therapeutics's products using the following success metrics.
Overview
Aileron Therapeutics is 23 yrs old and is based in United States.
Aileron Therapeutics is a clinical stage company focused on chemoprotection oncology. The company develops medicines aimed at making chemotherapy safer and more effective, with a primary focus on reducing or eliminating chemotherapy-induced side effects. Aileron primarily serves the healthcare sector, specifically the oncology industry. It was founded in 2001 and is based in Boston, Massachusetts.
Incept Biosystems is 19 yrs old and is based in United States.
Incept BioSystems aims to develop nanoscale technologies that provide cell biologists the ability to obtain high value data about cell growth and behavior. Their technologies were developed to improve the in vitro manipulation, performance and viability for Premium Cell Management applications. On January 12, 2011, Incept BioSystems was acquired by ORIGIO. The terms of the transaction were not disclosed.
Demo Video
Leadership
Manuel C Aivado (Senior Vice President)
Christopher A Bleck (Chief Executive Officer)
Investors
Apple Tree Partners, Novartis Venture Funds
ORIGIO, Grand Angels
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Aileron Therapeutics has not claimed their profile.
Work for Aileron Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Aileron Therapeutics?
Claim your profile now.
Information not available because Incept Biosystems has not claimed their profile.
Work for Incept Biosystems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Incept Biosystems?
Claim your profile now.